title: Efficacy of electrochemotherapy in ulcerated basal cell carcinoma.
abstract: Basal cell carcinoma is the most common cutaneous malignant tumor, accounting for up to 80% of non melanoma skin cancers. Surgery, radiotherapy and chemotherapy have been for long time the main options for its treatment. Electrochemotherapy (ECT) is a novel local treatment successfully used in primary skin tumors. We report a case of a man affected by ulcerated basal cell carcinoma treated with ECT. In our case ECT was successful in the management of extensive basal cell carcinoma in clinical conditions whereas other approaches, would have been dangerous and inappropriate. To our knowledge, ECT must be considered as an alternative of traditional techniques when they are contraindicated in relation to the appearance of the lesions or the patient medical history.
authors: Department of Dermatology, Umberto I Hospital, University Sapienza, Rome, Italy. antoniorichetta@hotmail.com
authors: A G
authors: AG
authors: Richetta
authors: P
authors: P
authors: Curatolo
authors: S
authors: S
authors: D'Epiro
authors: M
authors: M
authors: Mancini
authors: C
authors: C
authors: Mattozzi
authors: S
authors: S
authors: Giancristoforo
authors: R
authors: R
authors: Rotunno
authors: S
authors: S
authors: Calvieri
mesh_terms: D000368:Aged; D000903:Antibiotics, Antineoplastic / Q000008:administration & dosage / Q000627:therapeutic use; D001761:Bleomycin / Q000008:administration & dosage / Q000627:therapeutic use; D002280:Basal Cell Carcinoma / Q000150:complications / Q000188:drug therapy*; D002986:Clinical Trials as Topic / Q000706:statistics & numerical data; D053672:Electrochemotherapy; D006801:Humans; D008297:Male; D009378:Neoplasms, Multiple Primary / Q000188:drug therapy; D012074:Remission Induction; D012878:Skin Neoplasms / Q000150:complications / Q000188:drug therapy*; D012883:Skin Ulcer / Q000188:drug therapy* / Q000209:etiology
chemical_list: D000903:Antibiotics, Antineoplastic; D001761:Bleomycin